Efficacy of interferon-γ and amphotericin B for the treatment of systemic murine histoplasmosis
Authors:
- Karl V ClemonsKCKarl V Clemons
- Jon E LutzJLJon E Lutz
- David A StevensDSDavid A Stevens
- 1 January 2001
- journal article
- Published by Elsevier in Microbes and Infection
- Vol. 3 (1) , 3-10
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Experimental histoplasmosis in mice treated with anti-murine interferon-γ antibody and in interferon-γ gene knockout miceMicrobes and Infection, 2000
- Antifungal mechanisms of activated murine bronchoalveolar or peritoneal macrophages forHistoplasma capsulatumClinical and Experimental Immunology, 1995
- In Vivo Activity Of Interferon- In Combination With Amphotericin B In The Treatment Of Experimental CryptococcosisThe Journal of Infectious Diseases, 1994
- Subcutaneously Administered Recombinant Interferon-γ in HumansJournal of Immunotherapy, 1994
- Optimal Circadian Timing Reduces the Myelosuppressive Activity of Recombinant Murine Interferon-γ Administered to MiceJournal of Interferon Research, 1993
- Killing of Histoplasma capsulatum by -interferon-activated human monocyte-derived macrophages: evidence for a superoxide anion-dependent mechanismJournal of Medical Microbiology, 1991
- The Intracellular Fate of Histoplasma capsulatum in Human Macrophages Is Unaffected by Recombinant Human Interferon-The Journal of Infectious Diseases, 1990
- Pharmacokinetics of Recombinant Murine Interferon-γ in MiceJournal of Interferon Research, 1988
- Pharmacokinetics of Recombinant Murine Interferon-γ and Human Interferon-αA/D(Bgl) Administered in Concert and Their Influence on Natural Killer Cell Function in MiceJournal of Interferon Research, 1988
- Histoplasmosis and AIDSThe Journal of Infectious Diseases, 1988